newsfilter
← Latest News
PR Newswire·

Qualigen Therapeutics Issues CEO Letter to Stockholders with 2021 Outlook

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and...